JJ Rabinowich has spent his career at the intersection of policy, operations, and capital in long-term care, and he says the single biggest predictor of a hospital readmission isn't a resident's diagnosis. It's whether a family member's guilt shows up in the case file.
In this episode of Care, Code, and Capital, Dan Brody sits down with JJ Rabinowich, Founder and Executive Director of the Ambassadors Group, to discuss the state of long-term care advocacy, how AI is actually being used inside skilled nursing operations, the legal gray areas nobody has solved yet, and what the silver tsunami means for the future of the industry.
JJ's path into long-term care started in advocacy, running the West Coast office of a national organization before moving into state level lobbying in Chicago and eventually opening his own regulatory consulting practice. In January 2020, he helped found the Ambassadors Group to give skilled nursing operators a stronger, more unified voice in Washington, D.C., just months before COVID turned the organization into the industry's daily source of regulatory guidance.
In this conversation, Dan and JJ discuss:
• JJ Rabinowich's path from advocacy work to long-term care lobbying
• Founding the Ambassadors Group and its January 2020 launch
• Becoming the industry's information hub during COVID
• Why families are a bigger factor in hospital readmissions than most operators realize
• Using AI to prepare and stress test state survey plans of correction
• The legal gray areas around AI, attorney client privilege, and HIPAA
• Why evaluating new AI vendors has become a full time job for operators
• The silver tsunami and the case for skilled nursing as a care model
• Why states like Indiana are rethinking managed Medicaid
• Advice for young operators on partnerships and capital
JJ's take on what matters most in this industry:
"Provide quality care. That's eighty percent of the battle."
This episode is for skilled nursing operators, long-term care lobbyists and advocates, healthcare investors, and anyone trying to make sense of how AI regulation is catching up to healthcare.